Investigation of complete-response rate of intralesional immunotherapy with Candida antigen for the treatment of molluscum contagiosum
Phase 1
Recruiting
- Conditions
- Molluscum contagiosum.Molluscum contagiosum
- Registration Number
- IRCT20180411039265N2
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
acquisition of patient and parents' consent
Exclusion Criteria
Pregnant or lactating women
Violation of initial safety conditions or iatrogenic decease
Infection with HIV1
Increased sensitivity to Candida antigen
Reception of any treatment in relation to molluscum during the past month
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Complete-response, relative-response or no-response to the treatment of lesions. Timepoint: Monthly immunotherapy continues until the mucosal lesions completely disappear and for molluscums with less or no-response, it continues for a maximum of 6 treatment sessions. Method of measurement: Number and level of molluscums are written down.
- Secondary Outcome Measures
Name Time Method